Esophageal leiomyoma: a rare cause of dysphagia. of dysphagia. Report of a case
DOI:
https://doi.org/10.35954/SM2017.36.2.6Keywords:
Leiomyoma; Esophageal NeoplasmsAbstract
Leiomyoma is the most common benign esophageal tumor, although it is a rarity. benign esophageal tumor, although it constitutes a real rarity.
It represents 0.4% of all esophageal tumors, far behind malignant tumors. It is more frequent in men (1.9 times more common than in women), with an average age of 44 years, is slow-growing and sometimes almost asymptomatic.
slow-growing and sometimes almost asymptomatic, so delay in diagnosis is not uncommon. Malignant degeneration is exceptional. The most common symptoms are dysphagia, retrosternal pain, pyrosis and thinning. Endoscopy and echoendosonography allow the diagnosis to be completed. Surgery is indicated in symptomatic tumors, and the mini-invasive approach is the technique of choice. invasive approach is the technique of choice.
Downloads
Metrics
References
(1) Seremetis MG, Lyons WS, De Guzmán VC, Peabody Jr JW. Leiomyoma of the oesophagus. An analysis of 838 cases. Cancer 1976; 38:2166-75.
(2) Ha C, Regan J, Cetindag IB, Ali A, Mellinger JD. Benign Esophageal Tumors. Surg Clin N Am 2015; 95(3: 491-514.
(3) Delgado-Sánchez JJ, González-Vega M. Leiomioma esofágico. Rev Esp Med Legal 2015; 41(2):85-6.
(4) Jiang W, Rice TW, Goldblum JR. Esophageal leiomyoma: experience from a single institution. Dis Esophagus 2013; 26(2):167-74.
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 Martin Varela Vega, Sebastián Ibarra, Fabio Madera, Santiago Cubas, Gerardo Beraldo, José Cabillon, Pablo Santiago. The author retains his copyright and assigns to the journal the right of first publication of his work, which will be simultaneously subject to the Creative Commons Attribution 4.0 International License that allows sharing the work as long as the initial publication in this journal is indicated.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Until 2024 we use the Creative Commons Attribution/NonCommercial Attribution 4.0 International License https://creativecommons.org/licenses/by-nc/4.0/deed.es. Which states that: you are free to share, copy and redistribute the material in any medium or format, as well as to adapt, remix, transform and build upon the material. Under the following terms:
Attribution: you must give proper credit , provide a link to the license, and indicate if changes have been made . You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is endorsed by the licensor.
NonCommercial: you may not use the material for commercial purposes.
As of 2025 authors retain their copyright and assign to the journal the right of first publication of their work, which shall simultaneously be subject to the license https://creativecommons.org/licenses/by-nc-sa/4.0/deed.es that permits sharing, copying and redistribution of the material in any medium or format provided that initial publication in this journal is indicated. Adapt, remix, transform and build upon the material. If you remix, transform, or build from the material, you must distribute your contribution under the same license as the original and may not make use of the material for commercial purposes.
Under the following terms:
1. Attribution: you must give proper credit, provide a link to the license, and indicate whether changes have been made. You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is endorsed by the licensor.
2. NonCommercial: you may not use the material for commercial purposes.
3. ShareAlike: if you remix, transform or build upon the material, you must distribute your contribution under the same license as the original.
PlumX Metrics
/
